To evaluate the effects of MYBL2 knockdown on E2F1 overexpression or E2F7 knockdown in a more physiologically relevant setting, we performed tumor xenograft assays using genetically modified AGS sublines generated using the Tet-On system. This evidence concerns the gene MYBL2 and neoplasm.